These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 15026085

  • 1. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
    Gutzman JH, Miller KK, Schuler LA.
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):69-77. PubMed ID: 15026085
    [Abstract] [Full Text] [Related]

  • 2. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.
    Llovera M, Pichard C, Bernichtein S, Jeay S, Touraine P, Kelly PA, Goffin V.
    Oncogene; 2000 Sep 28; 19(41):4695-705. PubMed ID: 11032019
    [Abstract] [Full Text] [Related]

  • 3. Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.
    Rasmussen LM, Frederiksen KS, Din N, Galsgaard E, Christensen L, Berchtold MW, Panina S.
    Endocr Relat Cancer; 2010 Sep 28; 17(3):809-22. PubMed ID: 20601496
    [Abstract] [Full Text] [Related]

  • 4. Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells.
    Duan R, Ginsburg E, Vonderhaar BK.
    Mol Cell Endocrinol; 2008 Jan 16; 281(1-2):9-18. PubMed ID: 18022314
    [Abstract] [Full Text] [Related]

  • 5. Differences in prolactin receptor (PRLR) in mouse and human fallopian tubes: evidence for multiple regulatory mechanisms controlling PRLR isoform expression in mice.
    Shao R, Nutu M, Weijdegård B, Egecioglu E, Fernandez-Rodriguez J, Tallet E, Goffin V, Ling C, Billig H.
    Biol Reprod; 2008 Oct 16; 79(4):748-57. PubMed ID: 18596217
    [Abstract] [Full Text] [Related]

  • 6. Re-evaluation of the prolactin receptor expression in human breast cancer.
    Galsgaard ED, Rasmussen BB, Folkesson CG, Rasmussen LM, Berchtold MW, Christensen L, Panina S.
    J Endocrinol; 2009 Apr 16; 201(1):115-28. PubMed ID: 19153125
    [Abstract] [Full Text] [Related]

  • 7. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.
    Manhès C, Kayser C, Bertheau P, Kelder B, Kopchick JJ, Kelly PA, Touraine P, Goffin V.
    J Endocrinol; 2006 Aug 16; 190(2):271-85. PubMed ID: 16899561
    [Abstract] [Full Text] [Related]

  • 8. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
    Hou L, Xu B, Mohankumar KM, Goffin V, Perry JK, Lobie PE, Liu DX.
    Int J Oncol; 2012 Dec 16; 41(6):2285-95. PubMed ID: 23064471
    [Abstract] [Full Text] [Related]

  • 9. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
    Murphy LC, Peng B, Lewis A, Davie JR, Leygue E, Kemp A, Ung K, Vendetti M, Shiu R.
    J Mol Endocrinol; 2005 Apr 16; 34(2):553-66. PubMed ID: 15821116
    [Abstract] [Full Text] [Related]

  • 10. Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin.
    Trott JF, Horigan KC, Gloviczki JM, Costa KM, Freking BA, Farmer C, Hayashi K, Spencer T, Morabito JE, Hovey RC.
    J Endocrinol; 2009 Jul 16; 202(1):153-66. PubMed ID: 19401343
    [Abstract] [Full Text] [Related]

  • 11. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C, Matthews J, Tujague M, Wan J, Ström A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K.
    Cancer Res; 2007 Apr 15; 67(8):3955-62. PubMed ID: 17440111
    [Abstract] [Full Text] [Related]

  • 12. Prolactin regulation of estrogen and progesterone receptors in normal and neoplastic mouse mammary tissue.
    Koseki Y, Cole D, Matsuzawa A, Costlow ME.
    Jpn J Cancer Res; 1987 Oct 15; 78(10):1105-11. PubMed ID: 3119544
    [Abstract] [Full Text] [Related]

  • 13. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y, Li X, Jiang J, Frank SJ.
    Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland.
    Hovey RC, Trott JF, Ginsburg E, Goldhar A, Sasaki MM, Fountain SJ, Sundararajan K, Vonderhaar BK.
    Dev Dyn; 2001 Oct 07; 222(2):192-205. PubMed ID: 11668597
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.
    Kansra S, Yamagata S, Sneade L, Foster L, Ben-Jonathan N.
    Mol Cell Endocrinol; 2005 Jul 15; 239(1-2):27-36. PubMed ID: 15950373
    [Abstract] [Full Text] [Related]

  • 16. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
    Zaretsky JZ, Barnea I, Aylon Y, Gorivodsky M, Wreschner DH, Keydar I.
    Mol Cancer; 2006 Nov 05; 5():57. PubMed ID: 17083744
    [Abstract] [Full Text] [Related]

  • 17. Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor alpha in T47D breast cancer cells.
    Chen Y, Huang K, Chen KE, Walker AM.
    Breast Cancer Res Treat; 2010 Apr 05; 120(2):369-77. PubMed ID: 19377875
    [Abstract] [Full Text] [Related]

  • 18. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
    Balasenthil S, Barnes CJ, Rayala SK, Kumar R.
    FEBS Lett; 2004 Jun 04; 567(2-3):243-7. PubMed ID: 15178330
    [Abstract] [Full Text] [Related]

  • 19. Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line.
    Miyai S, Yoshimura S, Iwasaki Y, Takekoshi S, Lloyd RV, Osamura RY.
    Cell Tissue Res; 2005 Nov 04; 322(2):269-77. PubMed ID: 16133148
    [Abstract] [Full Text] [Related]

  • 20. Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.
    Tan D, Chen KE, Khoo T, Walker AM.
    Cancer Lett; 2011 Nov 01; 310(1):101-8. PubMed ID: 21775057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.